Search

everythinglearnresearchcommunity

for

Search:↓

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

Spironolactone effectively treats female pattern hair loss with few side effects.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Older age and certain lifestyles are linked to thinner, weaker hair, while how you see your hair relates to its thickness.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.